Monoamine oxidase A inhibitors

PheWeb

MAOI_A

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC N06AG

5119

Check pre-conditions, main-only, mode, ICD version None

2939

Check minimum number of events

Min. number of events 3

2939

Include endpoints None

2939

MAOI_A

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Monoamine oxidase A inhibitors based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	2886	1732	1154
Unadjusted prevalence (%)	0.94	1.00	0.85
Mean age at first event (years)	44.11	43.41	45.15

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.20 [0.84, 1.70]	3.1e-1	190
15 years	0.01	0.88 [0.63, 1.23]	4.4e-1	84
5 years	0.00	1.03 [0.65, 1.64]	9.0e-1	22
1 year	0.00	2.64 [1.37, 5.08]	3.7e-3	10

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: MAOI_A – Monoamine oxidase A inhibitors
GWS hits:

Survival analyses between endpoints

↥

Plot

before Monoamine oxidase A inhibitors
after Monoamine oxidase A inhibitors

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Monoamine oxidase A inhibitors

↥